Medicare Enrolled
Dr. Bassel Noumi, M.D.
Pulmonary Disease · Clifton, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Noumi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Noumi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Noumi
Dr. Bassel Noumi is a pulmonary disease specialist in Clifton, NJ, with 15 years of NPI registration. Based on federal Medicare data, Dr. Noumi performed 4,614 Medicare services across 1,958 unique beneficiaries.
Between the years covered by Open Payments, Dr. Noumi received a total of $5,354 from 29 pharmaceutical and/or device companies across 302 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Noumi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 6% volume in NJ
$5,354 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,614
Medicare services
Top 6% in NJ for pulmonary disease
1,958
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~308 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Nursing facility ventilation assistance and management This service involves the assistance and management of a patient's breathing support within a nursing facility setting. |
1,430 | $40 | $79 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
616 | $67 | $117 |
| Albuterol inhalation solution, 1 mg A unit dose of FDA-approved albuterol solution administered via durable medical equipment for inhalation. |
381 | $0 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
359 | $106 | $217 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
355 | $177 | $468 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
230 | $141 | $323 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
164 | $71 | $155 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
142 | $101 | $167 |
| Inpatient or observation ventilation management Follow-up care for a patient receiving ventilator support during an inpatient stay or observation period. This service involves the ongoing management and adjustment of breathing assistance. |
138 | $53 | $107 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
127 | $16 | $31 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
125 | $35 | $100 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
122 | $50 | $98 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
112 | $50 | $106 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
83 | $126 | $281 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
75 | $137 | $288 |
| COVID-19 immunoassay detection test A laboratory test that uses an immunoassay method to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) through direct visual observation. |
61 | $40 | $75 |
| Insertion of non-tunneled central venous catheter A procedure to place a central venous catheter for infusion in patients aged 5 years or older. The catheter is inserted directly into a large vein without being tunneled under the skin. |
27 | $69 | $185 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
26 | $12 | $22 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
16 | $30 | $57 |
| New patient office visit, complex (60-74 min) | 14 | $192 | $373 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
11 | $157 | $305 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.6% high complexity
0.9% medium
98.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,354
Total received (2018-2024)
Avg $765/year across 7 years
Top 27% in NJ for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
302
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,238 (97.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$116 (2.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,501
2023
$800
2022
$692
2021
$472
2020
$575
2019
$776
2018
$538
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$653
GlaxoSmithKline, LLC.
$450
Avadel CNS Pharmaceuticals, LLC
$88
Boehringer Ingelheim Pharmaceuticals, Inc.
$67
Inspire Medical Systems, Inc.
$58
Philips North America LLC
$57
Insmed, Inc.
$34
Itamar Medical Inc
$29
Regeneron Healthcare Solutions, Inc.
$17
United Therapeutics Corporation
$17
Vifor Pharma, Inc.
$15
JAZZ PHARMACEUTICALS INC.
$15
Top 3 companies account for 79.3% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,862
AstraZeneca Pharmaceuticals LP
$1,748
Boehringer Ingelheim Pharmaceuticals, Inc.
$491
Actelion Pharmaceuticals US, Inc.
$150
Mylan Specialty L.P.
$129
Philips Electronics North America Corporation
$108
Avadel CNS Pharmaceuticals, LLC
$88
Covidien LP
$71
Insmed, Inc.
$68
Inspire Medical Systems, Inc.
$58
Philips North America LLC
$57
Circassia Pharmaceuticals Inc
$55
Advanced Respiratory, Inc
$53
United Therapeutics Corporation
$47
Novartis Pharmaceuticals Corporation
$46
Regeneron Healthcare Solutions, Inc.
$44
Takeda Pharmaceuticals U.S.A., Inc.
$44
GENZYME CORPORATION
$30
Itamar Medical Inc
$29
Gilead Sciences, Inc.
$29
Genentech USA, Inc.
$23
Olympus America Inc.
$20
Veran Medical Technologies, Inc.
$19
Vifor Pharma, Inc.
$15
JAZZ PHARMACEUTICALS INC.
$15
OptiNose US, Inc.
$15
kaleo, Inc.
$14
Sunovion Pharmaceuticals Inc.
$13
Teva Pharmaceuticals USA, Inc.
$12
Top 3 companies account for 76.6% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AUVI-Q · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · DUAKLIR PRESSAIR · DUPIXENT · FARXIGA · FASENRA · GLASSIA · INSPIRE · LUMRYZ · Life 2000 Ventilation System · NUCALA · OFEV · OPSUMIT · Perforomist · ProAir Digihaler · Respiratoriy Care Undiv · S&RC Und · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Single Use Aspiration Needle · Spin · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · Utibron · Veklury · WatchPATONE · Wellcentive Undiv · XOLAIR · XYWAV · Xhance · Xolair · Yupelri · Zemaira · inCourage · superDimension
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
636
Per 100K population
122.7
County median income
$87,137
Nearest hospital
ST JOSEPH'S UNIVERSITY MEDICAL CENTER INC
1.3 mi
1.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Noumi is a clinical cardiology specialist, with above-average Medicare volume (top 6% in NJ), with low-engagement industry engagement, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Noumi experienced with nursing facility ventilation assistance and management?
Based on Medicare claims data, Dr. Noumi performed 1,430 nursing facility ventilation assistance and management services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Noumi receive payments from pharmaceutical companies?
Yes. Dr. Noumi received a total of $5,354 from 29 companies across 302 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Noumi's costs compare to other pulmonary diseases in Clifton?
Dr. Noumi's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Noumi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Clifton
Browse pulmonary diseases in Clifton ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NJ
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NJ
Which NJ pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology